The spread of carbapenem-resistant Enterobacteriaceae in South Africa: risk factors for acquisition and prevention

S Afr Med J. 2012 May 10;102(7):599-601. doi: 10.7196/samj.5789.

Abstract

New, effective antibiotics are only likely to become available in 15 - 20 years. To prevent deaths from untreatable Gram-negative infections in South Africa, the rights of any doctor, whether in general or in hospital practice, to indiscriminately prescribe whatever antibiotic they wish, and in whatever fashion, must be challenged. Furthermore, although prevention of the emergence and subsequent spread of carbapenem-resistant Enterobacteriaceae (CRE) has focused on acute and chronic care facilities and inter alia on antibiotic exposure in these institutions, CRE may soon become an issue within entire communities, highlighting a role for public health authorities in CRE prevention efforts.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Carbapenems / therapeutic use
  • Enterobacteriaceae / drug effects*
  • Enterobacteriaceae / isolation & purification
  • Enterobacteriaceae Infections / drug therapy*
  • Enterobacteriaceae Infections / epidemiology*
  • Enterobacteriaceae Infections / prevention & control
  • Humans
  • Infection Control / methods*
  • Population Surveillance
  • Risk Factors
  • South Africa / epidemiology
  • beta-Lactam Resistance*

Substances

  • Anti-Bacterial Agents
  • Carbapenems